Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion
Macular edema secondary to retinal vein occlusion is commonly being treated with off-label intravitreal bevacizumab with good outcomes. A significant reduction in macular edema and improvement in visual acuity is seen following such a treatment with no serious adverse effects. In the reported case,...
Saved in:
Main Authors: | Manish Nagpal, Vikram Mehta, Kamal Nagpal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Case Reports in Ophthalmological Medicine |
Online Access: | http://dx.doi.org/10.1155/2011/679751 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
by: Tatsuya Yunoki, et al.
Published: (2013-01-01) -
Intravitreal Injections for Macular Edema Secondary to Retinal Vein Occlusion: Long-Term Functional and Anatomic Outcomes
by: Emilia Maggio, et al.
Published: (2020-01-01) -
injeksi intravitreal triamsinolon pada central retinal vein occlusion
by: Sherly Muchlis, et al.
Published: (2020-04-01) -
Effect of Vitreous Reflux after Intravitreal Aflibercept Injection for Macular Edema with Branch Retinal Vein Occlusion: A Real-World Study
by: Tetsuya Muto, et al.
Published: (2024-01-01) -
The Analysis of Correlative Factors of Visual Acuity with Intravitreal Conbercept Injection in Macular Edema Associated with Branch Retinal Vein Occlusion
by: Wenjuan Luo, et al.
Published: (2018-01-01)